Bespoke nootropic pouch manufacturing

Nootropic pouch manufacturer for calm focus, citicoline and B vitamins

Nicotine-free nootropic pouches for premium wellness brands go from bench sample to sealed, labelled can in Leicester, inside the scope of our HACCP and GMP certificate from BSI, and we develop and make every one as a nootropic pouch manufacturer. They carry L-theanine, citicoline, B vitamins and measured doses of caffeine, released over a session with no water and no capsule. Doses follow the research or the rules: L-theanine at the 97 to 250 mg used in human studies, citicoline up to its authorised 500 mg a day, and micronutrients at 15% or more of their NRV for a claim. Every batch ships with its certificate of analysis, and every active has a status record for each market.

Nootropic pouches are one of three families in our functional pouch range, built on one fibre platform. Five types cover most briefs.

• Calm focus: L-theanine on its own, for a stimulant-free pouch.
• Focus with caffeine: L-theanine with a measured dose of caffeine. Our caffeine and energy pouch manufacturing page sets out caffeine rules by market.
• Citicoline focus: citicoline alone or with L-theanine, within its authorised conditions of use.
• Micronutrient focus: pantothenic acid, vitamins B6 and B12, zinc and iodine, which carry authorised claims for mental performance, psychological function and cognitive function.
• Layered formulas: combinations of the above, on the same platform as our nicotine-free pouches.

The base is a plant-fibre matrix with a humectant, a sweetener system, flavour and cooling, sealed in a food-contact fleece. Moisture and fibre choice set how fast actives reach saliva.

Dose anchors from research and authorisations

We anchor each active to the dose used in human research, or to the condition attached to its authorisation or claim.

Doses are set per pouch or across the recommended daily number of pouches, and the label states the daily total. Your formula is yours: the blend, doses, release profile and data belong to your brand, as our formula ownership commitment sets out.

The pouch changes the experience, not the biology

Solubility and taste

L-theanine and citicoline both dissolve readily in water, so they move into saliva quickly, and L-theanine tastes mild and slightly savoury. The hard actives are the others: zinc salts are astringent, calcium pantothenate is bitter, and caffeine is bitter at any useful dose. A nootropic pouch needs its taste system built around its hardest active. Our flavour and taste masking work pairs sweeteners, a little salt and cooling agents with each blend, and coats or encapsulates the worst offenders. Profiles stay adult: mint, citrus, berry, coffee and botanical notes.

Absorption: what the pouch changes

Actives dissolve into saliva and are swallowed, so the gut does most of the absorbing. L-theanine's blood levels follow a similar course whether it comes from capsules or green tea (Scheid and colleagues, Journal of Nutrition, 2012). Citicoline is split into choline and cytidine, and in people oral doses raise blood choline and uridine, the form cytidine takes in humans (Wurtman and colleagues, Biochemical Pharmacology, 2000). The pouch changes the experience rather than the biology: no water, a release spread across the session, and a dose taken when it is wanted.

Stacking with caffeine

L-theanine and caffeine have been studied together in people at pouch-sized doses, with attention and alertness as the measured outcomes (Owen and colleagues, Nutritional Neuroscience, 2008; Haskell and colleagues, Biological Psychology, 2008). Once caffeine is in, caffeine rules apply in full: the caffeine statement and content on the label, EFSA's safety figures, and Finland's classification check above 100 mg per recommended daily dose. We recommend setting the L-theanine dose first and adding caffeine in steps, so one platform runs from stimulant-free to full strength.

Uniformity and stability

Microgram actives such as vitamin B12 and iodine go in through a premix, so each pouch carries its share, and blend uniformity is confirmed before pouching. Vitamins are the stability risk: they lose potency with moisture, heat and light, and riboflavin tints a white pouch yellow. We set overages from stability data, within the limits of each market. As of October 2026, European Commission guidance accepts vitamins in food supplements from 20% below to 50% above the declared value, and minerals from 20% below to 45% above, while added vitamins and minerals in US products must meet at least the declared value.

L-theanine, citicoline and the actives we leave out

We list an active only where its status is clear in the markets you sell in. This is the position as of October 2026.

Green tea L-theanine escapes novel food authorisation only in food supplements, so a pouch carrying it is sold as a food supplement in the EU. Some popular actives stay out of our pouches. Lion's mane is studied at gram-level daily amounts (Docherty and colleagues, Nutrients, 2023), and its status depends on the part used: in the EU the fruiting body and its water extracts are not novel, but mycelium powder is. Paraxanthine is not an authorised novel food in the EU or GB. Botanical extracts are specified by plant part and extract: in the EU, rhodiola root is not novel in food supplements and Panax ginseng is not novel in food, and neither carries an authorised claim. For Great Britain, we confirm each active's status separately before formulation. For capsules, gummies and drinks built on these actives, see our nootropic supplement manufacturing.

Status checks on every active come before formulation

Every project starts in development: bench samples in your flavours and doses, release testing in simulated saliva and a stability study in the final can, then a pilot batch before full production in Leicester. You sign off each stage. Production then runs in six steps:

1. Check status. Before formulation, each active is checked against the novel food, food supplement and claims rules of every target market, and the outcome is written into the specification.
2. Specify and approve suppliers. We agree doses, pouches per can, release, moisture, water activity, flavour and shelf life with you. Supplier approval comes before any material is used, with a review every year, and each active arrives with a certificate of analysis for identity and purity.
3. Premix and weigh. Microgram vitamins and minerals are premixed with a carrier. Materials are weighed against the batch record under our allergen management plan, which uses yellow colour coding.
4. Blend and condition. Actives, filler, sweeteners, flavour and cooling agents are blended in a set order and brought to target moisture with humectant and water. Moisture and blend uniformity are checked before pouching.
5. Pouch, can and label. The blend is dosed into fleece and sealed, with checks on pouch weight and seal, then counted into cans. Label verification on every batch is the critical control point in our HACCP plan, CCP-01; for nootropic pouches it covers claim wording, the citicoline name and statement, and the caffeine statement where caffeine is present.
6. Retain and release. Three retained samples per batch are kept for shelf life plus one year. Every batch is released by quality control against its specification, and nothing is dispatched without quality control sign-off.

The pilot batch confirms blend order, moisture and pouch weight on the production line before the first full batch, and every later batch is made to the same batch record. The HACCP study for pouches is reviewed every year, and any non-conformance is closed with QA and Operations sign-off.

Release tests and the launch file you keep

British VitaTech is ISO 9001, HACCP and GMP certified by BSI, and FDA registered, and our pouches are GMP certified within that BSI scope. BRCGS implementation under way, certification expected in early 2027. Every batch is tested by accredited partner laboratories (ISO/IEC 17025) as part of every order; your specification sets the release tests.

• Actives: L-theanine, citicoline and caffeine by HPLC, at release and across shelf life.
• Micronutrients: vitamins by HPLC or microbiological assay, and zinc and iodine by ICP-MS, with content uniformity across pouches for microgram doses.
• Release profile: simulated saliva at set time points during development.
• Moisture and water activity: against your specification, with water activity measured by methods such as ISO 18787.
• Microbiology and heavy metals: total viable count, yeasts, moulds and named pathogens; lead, cadmium and mercury against the UK and EU limits for food supplements.
• Stability: accelerated and real-time studies of every active, moisture, flavour and seal, which set the shelf life and the overages.

Each batch ships with its certificate of analysis and batch release confirmation, and your launch file holds the specification with its test methods, the stability report and the status record for every active in each market. Our testing and batch release page explains the full programme.

Opaque cans and artwork that avoids medicinal cues

• Cans: plastic or metal cans chosen for moisture barrier and opacity, to protect light-sensitive vitamins, with a peel-off seal until first opening. We arrange paper-based cans through our partner network.
• Label space: a can carries the supplement statements, any claim, the citicoline statement and, with caffeine, the caffeine statement in the same field of vision as the name. In the UK and EU, mandatory text needs an x-height of at least 1.2 mm, or 0.9 mm where the largest surface is under 80 cm².
• Presentation: artwork stays adult and avoids implying a medicinal effect, because presentation alone can make a product a medicine in the UK and EU.
• Child-resistant closures: tested to ISO 8317 and arranged through our partner network.
• Coding: a batch code and best before date on every can, tracing each can to its batch record.
• Recyclability: the EU Packaging and Packaging Waste Regulation has applied since 12 August 2026, with recyclability grades from 2030 at the earliest, so we choose cans and lids with those grades in mind.

Focus wording, authorised claims and novel food checks

United Kingdom

As of October 2026, nootropic pouches sold in Great Britain are food supplements, carrying the recommended daily dose, a warning not to exceed it, the varied diet statement and the out-of-reach statement. Claims come only from the GB nutrition and health claims register, in authorised wording such as "Pantothenic acid contributes to normal mental performance" or "Zinc contributes to normal cognitive function", with the nutrient at 15% or more of its NRV per daily portion. A brand name or tagline built on "focus" or "nootropic" can be read as a health claim, so it needs a related authorised claim beside it. Citicoline is an authorised novel food in GB, at up to 500 mg a day in food supplements. A UK and EU agreement now in negotiation would align GB food rules with EU law, so we document every active against both lists now. Northern Ireland follows EU rules.

European Union

EU food supplement rules set the same mandatory statements, and many member states require notification before launch. We check every active against the Union list of novel foods and the Commission's novel food status catalogue, and against national rules on botanicals and amino acids, which differ between member states. Neither L-theanine nor citicoline has an authorised claim, and botanical claims are on hold, not authorised, so unauthorised wording such as "boosts brain power" stays off the label and the micronutrient claims carry the message.

United States

As of October 2026, nootropic pouches are sold as dietary supplements: intended for ingestion, not presented as a conventional food, and described as releasing actives into saliva that is swallowed, because FDA does not regard products intended to enter the body directly through mucosal tissues as dietary supplements. Labels carry a Supplement Facts panel listing each active per serving. Cognition wording takes the form of structure and function claims such as "supports focus", each carrying FDA's disclaimer and notified to FDA once marketing starts. An active not marketed in the US before 15 October 1994 needs a new dietary ingredient notification to FDA ahead of launch, unless it has been present in the food supply as food in a form that has not been chemically altered. We are an FDA registered food facility for dietary supplements.

One UK pouch brand, a client since 2023, has grown from a small brand to over 30,000 units a month; our R&D team developed four distinct formulas for it and proposes formula updates when ingredients improve or market conditions shift. R&D is a paid stage that can be included with an order of the right size. Start your project with your actives, doses and markets, and we will build the pouch around them.

References: Owen and colleagues, Nutritional Neuroscience (2008); Haskell and colleagues, Biological Psychology (2008); Scheid and colleagues, Journal of Nutrition (2012); Wurtman and colleagues, Biochemical Pharmacology (2000); EFSA, opinion on L-theanine health claims (2011); Commission Implementing Decision 2014/423/EU on citicoline (2014); Commission Regulation (EU) No 432/2012 (2012); Regulation (EU) 2015/2283 on novel foods (2015).